Join us

Rhei Life at the 7th Annual International Conference „Good Distribution Practise, Cooperation and Partnership“

The 7th Annual International Conference „Good Distribution Practise, Cooperation and Partnership“…

Olivera Kravic has joined our team as Quality Assurance Specialist

Rhei Life is pleased to announce that as of April 1st 2022, Olivera Kravic has joined our team

2021 – A VERY STRONG YEAR FOR RHEI LIFE

athlete woman runner stretching leg and feet and preparing for trail running on a Countryside Road at Sunrise.Active,Jogging workout and sport healthy lifestyle concept.

In 2021, Rhei Life demonstrated great strength in a challenging market environment, generating growth across all divisions.

A NEW PARTNERSHIP FOR LAUNCHING RHEI LIFE CHC PRODUCTS IN SOUTHEAST ASIA – MYANMAR

Two products from our CHC portflio will be launched in H2 2022. in Myanmar due to signed partnership with company Healthy Max from Myanmar.

SUPPLY OF BCG VACCINES TO CROATIA EXTENDED FOR THREE MORE YEARS

Vaccination concept image with Coronavirus Covid-19 SARS-CoV-2 virus vaccine - panoramic banner

Along with our partners, we have extended the contract for BCG vaccine supply with the Croatian Institute for Public Health for an additional 3 years, above the 3 years already in collaboration.

SHILPA MEDICARE LTD. – A NEW PARTNERSHIP

A new agreement has been signed and a new partnership confirmed with one of the most innovative Indian pharmaceutical companies.

NEW REGULATORY AFFAIRS ASSOCIATE FOR BIH APPOINTED

Hand adding a new team member to a group. Business management concept

Selma Alić has joined Rhei Life as Regulatory Affairs Associate, with 7-year experience in RA and other different pharmaceutical fields. She holds a Master’s Degree in Pharmacy, from the University in Sarajevo.

TIGECYCLINE DOSSIER SUBMITTED FOR REGISTRATION IN SERBIAN ALIMS

close up of 3d microscopic blue bacteria

Tigecycline is used to treat certain serious bacterial infections when other antibiotics may not work. It is related to a class of drugs known as tetracycline antibiotics. This project is developed with our partner manufacturing company Anfarm from Greece.

First MA of manufacturer BHARAT SERUMS AND VACCINES granted in Bosnia for Liposomal Amphotericin 50mg

We successfully imported Liposomal Amphotericin B injection, as a non-registered medicine, to several markets in the Balkan region (Serbia, Bosnia and Herzegovina, Montenegro), with Bosnia and Herzegovina approving us the Marketing Authorization.

VINPOCETINE LAUNCHED IN BOSNIA

Close up of doctor hand reassuring her female patient at hospital. Closeup hands of medical doctor carefully holding patient's hands. Kind doctor giving real support for patient.

Our partner Amsal in Bosnia launched Memoxa 5mg (Vinpocetine) sucesfully, after more than a year of sucesful sales and marketing results with 10mg Memoxa (was launched last year)